Alpine Immune Sciences, Inc. ALPN
64.97 +64.97
Day range unavailable
52-week range unavailable
News
zacks.com Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline Alpine Immune Sciences (ALPN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
businesswire.com ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Alpine Immune…
prnewswire.com INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Alpine Immune Sciences, Inc. - ALPN NEW YORK , April 17, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS…
investorplace.com Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? Wise investors are placing some biotech stocks on their watchlists this month, as these companies have surged over 160%. With more predicted upside to these companies than we see today, one could…
fool.com Could This Stock Be the Next Biotech Buyout? Vera Therapeutics is developing a dual-action antibody to treat kidney disorders, with successful results from the first portion of a pivotal study. Recently, Vertex Pharmaceuticals acquired Alpine…
businesswire.com ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Alpine Immune…
zacks.com Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex Vertex (VRTX) is set to acquire Alpine Immune Sciences (ALPN) for $65 per share in cash. The transaction is likely to close by second-quarter 2024.
schaeffersresearch.com 2 Biotech Stocks Driving the Nasdaq Today The Nasdaq is leading the charge today, with biotech exchange-traded fund (ETF) SPDR S&P Biotech ETF (XBI) up over 2% today.
benzinga.com Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.
barrons.com Vertex Pharmaceuticals to Buy Alpine Immune in $4.9B Deal The acquisition is a bet on a drug under development to treat the kidney condition IgA nephropathy.
investors.com Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It Vertex Pharmaceuticals will pay $4.9 billion to acquire Alpine Immune Sciences. Alpine stock rocketed almost 21% on rumors of the deal.
benzinga.com Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session.
investorplace.com The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today Drug maker Alpine Immune Sciences (NASDAQ: ALPN ) got a $4.9 billion buyout offer from Vertex Pharmaceuticals (NASDAQ: VRTX ) after getting good news on a new drug. Povetacicept, an autoimmune drug,…
invezz.com Vertex may have to pay more than $65 for Alpine Immune stock ($ALPN) Alpine Immune Sciences Inc (NASDAQ: ALPN) is up 35% on Thursday after Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) said it will acquire the biotechnology company for $65 per share. Is Alpine…
invezz.com Vertex may have to pay more than $65 for Alpine Immune stock ($ALPN) Alpine Immune Sciences Inc (NASDAQ: ALPN) is up 35% on Thursday after Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) said it will acquire the biotechnology company for $65 per share. Is Alpine…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
marketwatch.com Vertex Pharma's $4.9 billion takeover of Alpine Immune expected to boost its rare-disease portfolio Vertex Pharmaceuticals Inc.'s acquisition of Alpine Immune Sciences Inc. makes strategic sense and will bolster the company's rare-disease franchise, analysts said Thursday.
proactiveinvestors.com Alpine Immune Sciences soars on $4.9bn Vertex takeover Alpine Immune Sciences Inc shares continued higher in pre-market trading, after soaring on Wednesday following news of the firm's US$4.9 billion takeover by Vertex Pharmaceuticals Incorporated.…- proactiveinvestors.com Alpine Immune Sciences soars on $4.9bn Vertex takeover Alpine Immune Sciences Inc shares continued higher in pre-market trading, after soaring on Wednesday following news of the firm's US$4.9 billion takeover by Vertex Pharmaceuticals Incorporated.…
investopedia.com Vertex Stock in Focus After Deal to Buy Alpine Immune For $4.9B—Key Level to Watch Vertex Pharmaceuticals (VRTX) will acquire clinical-stage immunotherapy company Alpine Immune Sciences (ALPN) in a deal valued at around $4.9 billion, both companies said Wednesday.
prnewswire.com Shareholder Alert: Ademi LLP investigates whether Alpine Immune Sciences, Inc. has obtained a Fair Price in its transaction with Vertex MILWAUKEE , April 10, 2024 /PRNewswire/ -- Ademi LLP is investigating Alpine (Nasdaq: ALPN) for possible breaches of fiduciary duty and other violations of law in its transaction with Vertex. Click…
geekwire.com Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.
businesswire.com ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Alpine Immune Sciences, Inc. (NASDAQ: ALPN) to Vertex Pharmaceuticals Incorporated for…
benzinga.com Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results.- benzinga.com Earnings Scheduled For March 18, 2024 Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.
benzinga.com Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
benzinga.com Starbucks, Teleflex, Roku, Shopify And Other Big Stocks Moving Higher On Thursday U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Thursday. Here are some big stocks recording gains in today’s session.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023 - benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
benzinga.com Earnings Scheduled For March 23, 2023 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.- benzinga.com Earnings Scheduled For November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 413 companies reached new 52-week lows.
- benzinga.com 58 Biggest Movers From Yesterday Gainers
benzinga.com 73 Biggest Movers From Yesterday Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday.- benzinga.com 50 Stocks Moving In Tuesday's Mid-Day Session Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 209 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 105 stocks hit new 52-week lows.
- benzinga.com 60 Biggest Movers From Yesterday Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares jumped 88% to settle at $36.08 on Thursday.
- benzinga.com 62 Biggest Movers From Yesterday Gainers Universal Security Instruments, Inc. (NYSE: UUU) shares climbed 62.3% to close at $5.00 on Tuesday. DPW Holdings, earlier during the month, entered into agreement to purchase a 9.9% equity…
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday Wednesday morning saw 335 companies set new 52-week highs.
- benzinga.com Benzinga's Top Upgrades, Downgrades For December 21, 2020
- benzinga.com Earnings Scheduled For November 12, 2020 Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 per share on revenue of $25.37 million. • Alithya Group (NASDAQ:ALYA) is expected…
- benzinga.com 75 Biggest Movers From Friday Gainers Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) shares rose 95% to close at $39.00 on Friday after the company priced its IPO at $20 per share.
- benzinga.com 62 Biggest Movers From Yesterday Gainers
- benzinga.com 84 Biggest Movers From Yesterday Gainers
- benzinga.com Earnings Scheduled For March 30, 2020
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018